KATY, Texas, Dec. 20, 2018 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (Nasdaq:LGIH) announces the debut of its latest project in the greater Houston area, Freeman Ranch. Located in Katy, Texas near Houston’s Energy Corridor, this new 840-home community will …
BALTIMORE, Dec. 20, 2018 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, has announced the appointments of Monil Shah, PharmD, MBA, as Chief Development Officer …
CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of novel cellular immunotherapies, today announced that it has been selected for addition to …
Met primary endpoint with robust statistical significance Third positive Phase III study for SPN-812 in patients with ADHD Showed efficacy on both hyperactivity/impulsivity and inattention subscales with statistical significance Showed …
THE WOODLANDS, Texas, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced topline results from Phase 1 clinical studies of LX2761, an oral sodium-glucose cotransporter type 1 (SGLT1) inhibitor in development for …
HOUSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the appointment of Judith …
DENVER, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Internet Reputation (a subsidiary of Marca Global LLC) today announced a new custom brand reputation audit offering. The offering is designed to give executive-level reputation management clients and their …
Preparing for Next Generation IoT/Mobile Applications San Diego, CA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher”), a company specializing in the development of Internet of Things (IoT) and …
Phase 3 geographic atrophy program enrollment timeline currently unchanged; program enrollment is expected to restart in Q2 2019 and enrollment completion is expected in Q1 2020 CRESTWOOD, Ky. and WALTHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Apellis …
CRANBURY, N.J., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, today announced the dosing of the first …
Capital spending $300 million less than previously forecast Record thermal production in Q4 2018; Full rates achieved at Sunrise, Tucker and Rush Lake 2 CALGARY, Alberta, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Husky Energy plans to spend approximately $3.4 …
NEW YORK and STOCKHOLM, Sweden, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Christopher Engman, a global technology entrepreneur, investor, author and expert in driving rapid revenue growth, has joined Proof Analytics as chief revenue officer and chief marketing …
HOUSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Rosehill Resources Inc. (“Rosehill” or the “Company”) (NASDAQ: ROSE, ROSEW, ROSEU) today announced its 2019 guidance along with an operational update. Highlights Estimated 2019 annual production guidance of 20 – …
SAN FRANCISCO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today announced that roxadustat, an inhibitor of hypoxia-inducible- …
MINNEAPOLIS, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTS) (the “Company”), a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories, announced today that its Board of …
DUBLIN, Ireland, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of innovative anti-infective agents to treat serious infections, announced the …
BOULDER, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it will present new data from …
BRISBANE, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for …
NASHUA, N.H., Dec. 20, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology company providing innovative cancer detection and therapy solutions, today announced that it has entered into definitive agreements to sell unsecured …
VALLEY COTTAGE, N.Y. , Dec. 20, 2018 (GLOBE NEWSWIRE) -- Future Market Insights (FMI) delivers key insights on the global copier paper market in its published report, titled “Copier Paper Market: Global Industry Analysis 2013-2017 and Opportunity …
05 days 06:29:57
